Anzeige
Mehr »
Samstag, 11.04.2026 - Börsentäglich über 12.000 News
0,01% von 1 BILLIONEN USD = 100 MILLIONEN USD - Und UberDoc ist gerade erst an die Börse gegangen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40LMS | ISIN: US80303D3052 | Ticker-Symbol:
NASDAQ
10.04.26 | 21:59
16,890 US-Dollar
-7,25 % -1,320
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SANUWAVE HEALTH INC Chart 1 Jahr
5-Tage-Chart
SANUWAVE HEALTH INC 5-Tage-Chart

Aktueller Chart SANUWAVE HEALTH Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
SANUWAVE HEALTH INC-Investoren interessieren sich auch für diese Wertpapiere
IRIDEX Corporation: Iridex Announces Plans to Relocate HeadquartersMOUNTAIN VIEW, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
► Artikel lesen
IRIDEX Corporation: Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse Technology and Continuous-Wave Laser for Glaucoma TreatmentMOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
► Artikel lesen
IRIDEX Corporation: Iridex Reports Third Quarter 2025 Financial ResultsMOUNTAIN VIEW, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
► Artikel lesen
MDxHealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026Mdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 IRVINE, California -...
► Artikel lesen
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact SciencesMDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences IRVINE, CA - January 12, 2026 (GlobeNewswire) -...
► Artikel lesen
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 Q3 revenues increased by 18% to $27.4 millionAdjusted EBITDA profitability of $1.0 million for Q3Acquisition...
► Artikel lesen